This site uses cookies.
Most of these are necessary for the site to function. We also use analytical cookies to improve user experience, highlight issues and gather statistical information.
For more information you can read how we use them in our Cookie policy

Accept & Close

News and Updates

 

Patient Voices in Rheumatology Educational Course

Join the BSR for its new Patient Voices in Rheumatology course taking place in London on Friday, 27 June.

You’ll learn about improving patient interactions, empowering patients in their care, addressing diverse needs, and involving patients in service design and research.
Esteemed speakers include Dr. Melanie Sloan, Prof. Zoe Paskins, Prof. Sarah Ryan, Dr. Charlotte Sharp, Dr. Rosemary Hollick, NASS representatives, and keynote speaker Dr. Simon Stones.

Bursaries up to £300 are available for registration or travel expenses.

Find out more on the British Society for Rheumatology website.

 

New Resource: Standard Responses to Referrals and Requests for Specialist Advice

BSR has developed standard responses to referrals and requests for specialist advice with input from clinicians and specialist across the UK. We hope these documents will help your department to more efficiently respond to common advice requests from referrers. You can find out more on our website, where you will also find our Referral Criteria Guidance and Best Practice resources: https://www.rheumatology.org.uk/improving-care/specialist-advice-referral-and-triage.

National Data Opt-out (NDO) Update

The National Early Inflammatory Arthritis Audit (NEIAA) is no longer exempt from the National Data Opt-out (NDO), as of 7 July 2023. Clinical teams must now check each patient's NDO status before submitting any confidential patient data into the audit. Further information can be found here.

Resources have been compiled by NHS Digital to support with NDO compliance, these can be found here.

Patient Eligibility From 1 April 23

Patient eligibility within the audit has changed from 1 April 23. Patients should now only be entered into the audit when they have a confirmed diagnosis of EIA (Rheumatoid arthritis, Psoriatic arthritis, Axial spondyloarthropathy, Undifferentiated inflammatory arthritis). Year 4 data suggests this will result in a 65% reduction in data burden. In addition to this, patients with confirmed diagnosis of CTD and Systemic Vasculitis, a full list of diagnosis are listed here

CTD:
Systemic lupus erythematosus
Primary Sjogren’s syndrome
Systemic sclerosis
Idiopathic inflammatory myopathy
Undifferentiated/other connect tissue disease or overlap syndrome

Systemic Vasculitis:
Giant cell arteritis
Large vessel vasculitis (not giant cell arteritis)
Anti-neutrophil cytoplasmic antibody-associated vasculitis
Small/medium vessel vasculitis (anti-neutrophil cytoplasmic antibody-negative)
Behçet’s syndrome

There is more information about the changes to data collection here: Changes to The National Early Inflammatory Arthritis Audit (rheumatology.org.uk).

If you have any questions about these changes, please contact the team at audit@rheumatology.org.uk.

Sign up to the BSR newsletter

Yes please
Privacy policy
Thank you for getting in touch!
Company No: 3470316 | Charity No: 1067124

Contact

British Society for Rheumatology Bride House, 18-20 Bride Lane, London, EC4Y 8EE
T: +44 (0)20 8194 0532 E: audit@rheumatology.org.uk
Measuring CO2…Website Carbon